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Objectives: To discuss the clinical rules of TCM four diagnostic information and
relevant indicators in qi-deﬁciency-blood-stasis syndrome of congestive heart failure,
and consummate diagnosis criteria of the syndrome.
Methods: (1) Based on databases of CNKI (1980-2012) and VIP (1989-2012), related
modern literatures on CHF were reorganized and analyzed, and syndrome factors were
extracted from them. The pathogenesis and common syndromes of this disease got
analysized. (2) 1694 CHF cases from grade 3 and ﬁrst-class hospitals (from Dec, 2010
to Sep, 2012) were collected, with rank sum test, Spearman rank correlation analysis
and factor analysis by SPSS18.0. The correlations in qi-deﬁciency-blood-stasis syn-
dromes and age, sex, primary illnesses, lab index, major and minor symptoms had
been studied. (3) 750 CHF cases from multicenter (from Dec, 2012 to Dec, 2013) were
collected by applying TCM syndrome scale of congestive heart failure. The threshold
values in clinic diagnosis of qi-deﬁciency-blood-stasis syndrome got determined by
applying maximum likelihood method combined with ROC curve. The manifestations
of tongue and pulse got analysized by logistic regression. Reference range of BNP
also got described by the mean value and median.
Results: (1) Literature analysis indicates: Syndrome factors on disease location of
CHF are the heart, kidney, lung, and the spleen. Factors on natures of this disease
sorted from more to less is qi deﬁciency, blood stasis, yang deﬁciency, yin deﬁciency,
yang exhausted, water retention, etc. The pathogenesis of CHF mainly is deﬁciency
complicated with excess, and qi-deﬁciency-blood-stasis syndrome is the common
pattern of this disease. (2) Retrospective analysis of clinical cases indicates: There are
367 cases of qi-deﬁciency-blood-stasis syndrome in 1694 CHF cases. It mostly can be
seen in male patients aged 50-70 and female patients aged over 70 years old. The
primary disease mainly is coronary heart disease. And it also has correlation with
BNP. The major symptoms of it are chest suppression, palpitation, short breath, dark-
red tongue, white fur and thin pulse. The minor one is thin fur. (3) Syndrome scale
analysis showed: The diagnosis criteria of CHF qi-deﬁciency-blood-stasis syndrome is
total score of related items is equal or greater than 76 points (sensitivity: 96.9%,
speciﬁcity: 86.9%). The results of retrospective and prospective clinical assess showed
the sensitivity and speciﬁcity was above 90%. The common manifestations of tongue
and pulse are purple tongue with petechia and uneven pulse. And the reference range
of BNP is from 209.33 to 316.57 pg/ml.
Conclusions: The essential syndrome of congestive heart failure is qi-deﬁciency
-blood-stasis syndrome. The clinical distribution links to patients’ age and gender.
Congestive heart failure mostly develops from coronary heart disease. The syndrome
scale of CHF has higher sensitivity and speciﬁcity, which is available to the clinical
application.
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Decreased plasma relaxin-3 levels in patients with chronic heart failure
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Objectives: Relaxin-3 has been found to alleviate isoproterenol-induced myocardial
ischemia injury and have anti-ﬁbrotic action. The role of endogenous relaxin-3 on
chronic heart failure (CHF), however, remains unknown.
Methods: We investigated the levels of plasma relaxin-3 and their relationship to
cardiovascular function in patients with CHF. We studied 31 patients who were
admitted with CHF that was caused by left ventricular systolic dysfunction [New York
Heart Association (NYHA) functional class III or IV] and 38 age-matched healthy
subjects. Blood samples were taken at study entry, and the relaxin-3, relaxin-2 and N-
terminal pro-brain natriuretic peptide (NT-pro BNP) were measured. Cardiac structure
and function were measured by echocardiography.
Results: Relaxin-3 levels were signiﬁcantly lower in CHF patients than in controls:
the median plasma relaxin-3 concentration was 57.41 pg/ml (range, <49.56-64.42 pg/
ml) in patients with CHF and 69.37 pg/ml (range, <63.90-72.97 pg/ml) in controls
(P<0.001). However, no differences in relaxin-2 levels were observed between the
CHF group and controls (P¼0.505). The plasma levels of relaxin-3 positively
correlated with total cholesterol (r¼0.39, P¼0.032) and NT-pro BNP (r¼0.39,
P¼0.032) in patients with CHF. Plasma relaxin-3 concentration showed no statisti-
cally signiﬁcant associations with other component traits in patients with CHF.
Additionally, there was no correlation between the plasma concentrations of relaxin-3
and relaxin-2 in patients with CHF (r¼-0.25; P¼0.174).
Conclusions: We conclude that plasma relaxin-3 concentrations are decreased in
CHF, though low endogenous relaxin-3 levels are only related to total cholesterol and
NT-pro BNP.
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Diagnostic and predictive value of serum galectin-3 in patients with chronic heart
failure
Geng Fanqi, Yang Ping
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Objectives: Biological markers such as BNP and NT-proBNP have been widely used
in evaluation of the incidence and severity of heart failure clinically. However,
multiple mechanisms are involved in the pathophysiology process of heart failure,
thus, a single marker may not be sufﬁcient. Combination of several biological markers
may be more reliable. Galectin-3 is a new biological marker, which may participate inJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cthe regulation of cardiac ﬁbrosis and remodling. Therefore, it can be used in evalu-
ation of the incidence and severity of HF, it can also be used to predict prognosis in
patients with HF. In this study comparison of the level of serum galectin-3 in CHF and
Control, correlation analysis between the level of serum galectin-3 and LA, LVD,
LVEF and BNP in chronic heart failure were invested. Analyse and discuss the sig-
niﬁcance of serum galectin-3 in chronic heart failure. And compare of the diagnositic
value of Galectin-3 and BNP for CHF in both the sensitivity and speciﬁcity.
Methods: Patients with chronic heart failure were recruited. The signiﬁcance of heart
failure was determined by NYHA classiﬁcation II-IV. The level of serum galectin-3
was determined by sandwich ELISA. Echocardiography was performed to determine
the diastolic left atrial diameter (LA), left ventricular end-diastolic diameter (LVD)
and left ventricular ejection fraction (LVEF). Data were analyzed by SPSS 17.0,
P<0.05 was considered statistically signiﬁcant. Association of two sets of data was
evaluated with Pearson correlation analysis. Receiver-operating characteristic (ROC)
curve was used to analyze the prognostic value of galectin-3 or BNP for CHF.
Results: The level of serum galectin-3 was signiﬁcantly higher in the CHF group
compared with that in control; The differences of the level of serum galectin-3 be-
tween diffrernt sub-groups was statistically signiﬁcant (P<0.05 and P<0.01). The
level of serum galectin-3 was positively correlated with LA (r¼0.465, P<0.01) and
LVD (r¼0.643, P<0.01), but negatively correlated with LVEF (r¼-0.788, P<0.01).
The level of plasma BNP was positively correlated with LA (r¼0.464, P<0.01) and
LVD (r¼0.633, P<0.01), but negatively correlated with LVEF (r¼-0.799, P<0.01).
The level of serum galectin-3 was positively correlated with the level of plasma BNP
(r¼0.855, P<0.01). AUC was 0.808 when the level of serum galectin-3 was more than
8.61 ng/ml. The sensitivity to predict CHF was 77.1%, the speciﬁcity was 92.3%.
AUC was 0.903 when the level of plasma BNP was more than 1011 pg/ml. The
sensitivity to predict CHF was 81.6% and the speciﬁcity was 90.3%.
Conclusions: (1) The level of serum galectin-3 is related to the changes of left heart
structure and function, indicating that galectin-3 may be involved in the process of left
ventricular remodeling in CHF. (2) The speciﬁcity of galectin-3 is higher than BNP in
predicting CHF, not the sensitivity.
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Observation of effects of individualized rehabilitation guidance on patients with
heart failure after myocardial infarction
Gong Shuang, Liu Yue, Yang Bin
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Objectives: To explore the inﬂuence of individualized rehabilitation guidance for
improving heart function in patients with heart failure after myocardial infarction.
Methods: Enroll 106 hospitalized patients with heart failure after myocardial
infarction in the study, 52 male, 54 female, aging from 68 to 75, cardiac function
ranging from II to III levels. they all suffered from heart failure after myocardial
infarction and were treated with strong heart diuresis therapy. All 106 cases were
randomly divided into two groups (control group and vs. observation group), there
was no statistically signiﬁcant difference between them. Patients in control group were
treated with routine nursing care during hospital stay, while for patients in the
observation group, In addition to routine nursing instruction, individualized rehabil-
itation guidance was performed, including the rest and activity guidance, diet guid-
ance, defecation guidance, medication guidance, psychological guidance, guidance of
disease knowledge, and self-monitoring, et al. A 6 months follow-up was conducted
after discharge. The monitoring indicators including 6 minutes walking dis-
tance, B-type natriuretic peptide. heart function in hospital and 6 months after
hospitalization.
Results: 6 minutes walking distance in observation group increased signiﬁcantly than
the control group, the difference was statistically signiﬁcant (P<0.05). The level of
B-type natriuretic peptide decreased in 49 cases in the observation group, and in the
control group that was 42, the differences was statistically signiﬁcant (P<0.05).
Conclusions: Individualized inpatient rehabilitation guidance can help the patients
build up a good way of life, ensure the treatment effect, improve the patient’s heart
function and life quality.
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Objectives: To explore change and clinical signiﬁcance of the level of plasma ho-
mocysteine (HCY) in patients with dilated cardiomyopathy (DCM).
Methods: All subjects consisted of 116 consecutively hospitalized patients with
DCM, including 92 male patients and 24 female patients, aged from 18 to 70 years
old, whose average age was (47.412.7) years old and 30 age and sex matched pa-
tients with paroxysmal supraventricular tachycardia (non-attack period, without
structural heart disease) as controls. Electrocardiogram, chest X-ray and echocardi-
ography were routinely performed, as well as thyroid function and biochemical tests,
and coronary arteriongraphy when necessary. DCM is still a diagnosis by exclusion of
hypertension, coronary heart disease, rheumatic heart disease, congenital heart dis-
ease, diabetes mellitus, arteriosclerosis, etc. Blood samples were obtained to determineardiovascular Disease Clinical Research C187
plasma HCY and B-type natriuretic peptide (BNP) levels at the next morning after
admission of the patients of DCM and paroxysmal supraventricular tachycardia.
Results: Plasma HCY level in dilated cardiomyopathy group was signiﬁcantly higher
than in control group. Correlation analysis showed that plasma HCY level is positively
correlated with heart function and plasma BNP level, and is signiﬁcantly correlated
with left ventricular diastolic diameter and end-systolic diameter, and is negatively
correlated with ejection fraction.
Conclusions: Plasma HCY level was associated with the severity degree of heart
failure and was positively related to plasma BNP level. HCY may direct or indirect
affect the myocardium. Therefore, HCY may be a potential etiology of the occurrence
and development of chronic heart failure, which provides a new idea for the treatment
of chronic heart failure.
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The inﬂuence of depressive symptoms on plasma levels of soluble ST2, NT-pro
BNP and ghrelin in patients with systolic heart failure
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Objectives: Depression is a common psychological disorder in heart failure (HF)
patients with increased risks of mortality and reduced quality of life. The aim of this
study was to identify the inﬂuence of depressive symptoms on plasma levels of sol-
uble ST2 (sST2) and neurohormones [N-terminal pro-brain natriuretic peptide
(NT-pro BNP) and ghrelin] in patients with systolic HF.
Methods: A cohort of 146 HF patients with left ventricular ejection fraction (LVEF)
less than 40% was followed up for 1 year. The primary endpoint was all-cause
mortality and HF-related hospitalization. Psychological status was evaluated by
Hospital Anxiety and Depression Scale (HADS) and Hamilton Depression Scale
(HAMD). Plasma levels of sST2, NT-pro BNP and ghrelin were measured at baseline.
Patients were eligible if they were clinically diagnosed of HF, aged over 18 years, had
a LVEF less than 40% with New York Heart Association functional class II-IV and
treated with standard medications of HF for at least 3 months. Participants who had
myocardial infarction within 1 month, congenital heart disease, peripartum cardio-
myopathy, gastric diseases, malignant, current thyroid diseases, severe cognitive
dysfunction, severe dysfunction of the liver or renal were excluded. We also elimi-
nated patients with history of psychiatric diseases, or patients who were slated for
cardiac transplantation in the next 6 months.
Results: HF patients with depressive symptoms (n¼52, 35.6%) had higher levels of
sST2 (55.3 ng/ml vs. 41.1 ng/ml, P<0.001) and NT-pro BNP (5886 pg/ml vs. 2682
pg/ml, P<0.001), but lower levels of ghrelin (7.0 ng/ml vs. 7.9 ng/ml, P¼0.041),
compared with those without depressive symptoms. Levels of sST2 and NT-pro BNP
were independently associated with depressive symptoms. After 1-year follow-up, 33
patients (22.6%) died and 53 (36.3%) patients achieved the primary endpoint. The
hazard ratio (HR) of all-cause death and HF-related hospitalization was 2.2 [95%
conﬁdence interval (CI) 1.34-3.52, P¼0.002] in patients with depressive symptoms
when adjusted for clinical covariates, including age, gender, BMI, e GFR, LVEF,
NYHA class and NT-pro BNP. Depressive symptoms combined with upper risk
threshold levels (>36.0 ng/ml) of sST2 (HR 3.65, 95% CI 1.66-8.02, P¼0.001) or
NT-pro BNP (HR 2.99, 95% CI 1.24-7.21, P¼0.014) were independently associated
with increased risks of death and HF-related hospitalization. ROC curves showed that
the combination of depression scales (HAMD and depression subscale of HADS) with
sST2 or NT-pro BNP signiﬁcantly improved the prognostic value than sST2 or NT-
pro BNP alone (sST2+HAMD+HADS-D vs. sST2, P¼0.019; NT-pro
BNP+HAMD+HADS-D vs. NT-pro BNP, P¼0.016).
Conclusions: Depressive symptoms were independent risk factors of HF and provided
additional prognostic information to that of sST2 and NT-pro BNP for all-cause
mortality and HF-related hospitalization during 1-year follow-up.
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Analysis of Relationship between Clinical Features and Heart Failure in 214
acute ST-segment elevation Myocardial Infarction
Yu Yanan, Yang Ping
Jilin Provincial China-Japan union Hospital
Objectives: To analyze clinical data of 214 acute ST-elevation Myocardial Infarction
(STEMI) hospitalized patients in retrospecte, discuss the correlationshiop between
clinical features and heart failure in STEMI hospitalized patients.
Methods: It was retrospectively analyzed that involve 214 STEMI patients treated in
Jilin Provincial China-Japan union Hospital and receiced PCI from January 2013 to
December 2013. The 214 cases were divided into heart failure group (n¼78) and non-
heart failure group (n¼136) based on the Left ventricular ejection fraction. Analysis
two sets of data on a single factor, including hospitalization, medical history, ECG
changes, coronary angiography, laboratory tests, echocardiography related indicators
and therapy situations, then collect related risk factors (P<0.05) into multivariate
Logistic regression analysis to discovery independent risk factors for heart failure in
STEMI patients after PCI.
Results: There are 78 case in heart failure group and 136 case in non-heart failure
group. Clinical material characteristics : 48 case old patients in heart failure groupC188 JACC Vol 64/16/Suppl C j October 16–1while 56 case old patients in non-heart failure group, difference of age was statis-
tically signiﬁcant (P¼0.004).The heart rate (84.016.1) and the systolic blood
pressure (144.734.7) of heart failure group is higher than (75.416.4),
(136.425.4) in non-heart failure group. 13 case in heart failure group with Atrial
ﬁbrillation, 8 case in non-heart failure group with Atrial ﬁbrillation, it is tatistically
signiﬁcant. Analysis Coronary arteries between two group, STEMI patients with
multivessel disease has more probability to be heart failure (P¼0.00). Further divided
214 STEMI into Left anterior descending artery disease (126 case) and not Left
anterior descending artery disease (88case), primary artery difference was statistically
signiﬁcant (P<0.05).The analysis of different patency time between two group
conﬁrm that the earlier patency of the artery, the less the possibility of heart failure.
The analysis of laboratory parameters suggest that cTNI (27.1628.89) and BNP
(10221.436269.00) of heart failure patients with were higher than those of non-
heart failure group cTNI (4.759.69), BNP (2018.871752.81), both have signiﬁ-
cant difference (P<0.05). Analyze of treatment strategies of STEMI patients between
two group show that the use of ACEI and trimetazidine was signiﬁcantly higher in
on-heart failure group than in heart failure group. Single- factor statistic ﬁnd the
possible associated risk factors include age, heart rate, systolic blood pressure, Atrial
ﬁbrillation, Coronary arteries, Left anterior descending artery disease, different
patency time, BNP, cTNI, use of ACEI and trimetazidine. Further reaserch about the
possible associated risk factors in more factors Logistic regression analysis showed
that a STEMI patient with Left anterior descending artery diseaseand with higher
cTNI is more likely to be heart failure. And the use of trimetazidine will induce the
possibility
Conclusions: (1) The risk of STEMI patients with heart failure signiﬁcantly
increased with age, heart rate, high systolic blood pressure, Atrial ﬁbrillation, high
BNP, high cTNI, Multivessel disease and Left anterior descending artery disease. (2)
The use of trimetazidine and ACEI will induce the possibility of heart failure in
STEMI patients with conventional treatment after PCI. (3) Left anterior descending
artery diseaseand and higher cTNI were independent danger factor for STEMI
patients heart failure.
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Objectives: Pulmonary abnormalities are found in both chronic heart failure
(CHF) and pulmonary arterial hypertension (PAH). The differences of pulmonary
function in chronic left heart failure and chronic right heart failure are not fully un-
derstood. In the research, we evaluated the pulmonary function at both rest and ex-
ercise by cardiopulmonary exercise testing (CPX) in patients with chronic left heart
failure and right heart failure secondary to PAH and analyzed the differences in two
groups.
Methods: We successively evaluated patients with chronic left heart failure and
right heart failure secondary to PAH between October 2010 and December 2012.
All patients with right heart failure underwent right heart catheterization 3 days after
CPX to determine the pulmonary arterial pressure, cardiac index and pulmonary
capillary wedge pressure. All patients underwent echocardiography on the same
day before CPX, and CPX to determine the pulmonary function at both rest and
exercise.
Results: There were 120 patients involved in the study, including 60 patients with
chronic left heart failure and 60 patients with right heart failure secondary to PAH.
Patients with right heart failure were younger (30.89.5 years vs 45.19.9 years,
P<0.001), had less men (10 vs 53, P<0.001) and smoker (4 vs 37, P<0.001), and had
a lower BMI (22.132.95 kg/m2 vs 24.123.94 kg/m2, P¼0.002). Patients with right
heart failure had a signiﬁcantly lower end-tidal partial pressure of CO2 (33.724.47
mmHg vs 28.784.25 mmHg, P<0.001), higher end-tidal partial pressure of O2
(110.687.48 mmHg vs 115.806.65 mmHg, P<0.001) and minute ventilation/CO2
production (37.966.50 L/min/L/min vs 43.456.79 L/min/L/min, P<0.001) at rest.
Patients with right heart failure had a lower peak end-tidal partial pressure of CO2
(33.426.04 mmHg vs 24.325.30 mmHg, P<0.001), and a higher peak dead space
volume/ tidal volume ratio (27.184.02% vs 28.834.04%, P¼0.027), peak end-tidal
partial pressure of O2 (117.176.10 mmHg vs 124.435.61 mmHg, P<0.001), peak
minute ventilation/CO2 production (36.137.97 L/min/L/min vs 48.5011.95
L/min/L/min, P<0.001), and minute ventilation/CO2 production slope (32.747.52 vs
45.7016.18, P¼0.001) during exercise. Patients with right heart failure had lower
changes in end-tidal partial pressure of CO2 (-0.6114.16% vs -15.6112.91%,
P<0.001) and minute ventilation/CO2 production (4.5516.28% vs -11.4618.68%,
P<0.001) from rest to exercise.
Conclusions: Patients with right heart failure had worse pulmonary function at rest
and exercise. The differences in pulmonary function at rest were due to patients with
right heart failure had hyperventilation in some alveolar. The pulmonary function
differences during exercise were due to hyperventilation in some alveolar, severe
ventilation/perfusion mismatching, severe gas exchange abnormality and worse car-
diopulmonary adaptation to exercise.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
